Human-like NSG Mouse Glycoproteins Sialylation Pattern Changes the Phenotype of Human Lymphocytes and Sensitivity to HIV-1 Infection by Dagur, Raghubendra S. et al.
University of Nebraska Medical Center 
DigitalCommons@UNMC 
Journal Articles: Munroe-Meyer Institute Munroe-Meyer Institute 
2019 
Human-like NSG Mouse Glycoproteins Sialylation Pattern 
Changes the Phenotype of Human Lymphocytes and Sensitivity to 
HIV-1 Infection 
Raghubendra S. Dagur 
University of Nebraska Medical Center, raghu.dagur@unmc.edu 
Amanda Branch-Woods 
University of Nebraska Medical Center 
Saumi Mathews 
University of Nebraska Medical Center, saumi.mathews@unmc.edu 
Poonam S. Joshi 
University of Nebraska Medical Center 
Rolen M. Quadros 
University of Nebraska Medical Center, rolen.quadros@unmc.edu 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unmc.edu/mmi_articles 
 Part of the Developmental Psychology Commons, and the Medical Genetics Commons 
Recommended Citation 
Dagur, Raghubendra S.; Branch-Woods, Amanda; Mathews, Saumi; Joshi, Poonam S.; Quadros, Rolen M.; 
Harms, Donald W.; Cheng, Yan; Miles, Shana M.; Pirruccello, Samuel J.; Gurumurthy, Channabasavaiah B.; 
Gorantla, Santhi; and Poluektova, Larisa Y., "Human-like NSG Mouse Glycoproteins Sialylation Pattern 
Changes the Phenotype of Human Lymphocytes and Sensitivity to HIV-1 Infection" (2019). Journal 
Articles: Munroe-Meyer Institute. 4. 
https://digitalcommons.unmc.edu/mmi_articles/4 
This Article is brought to you for free and open access by the Munroe-Meyer Institute at DigitalCommons@UNMC. 
It has been accepted for inclusion in Journal Articles: Munroe-Meyer Institute by an authorized administrator of 
DigitalCommons@UNMC. For more information, please contact digitalcommons@unmc.edu. 
Authors 
Raghubendra S. Dagur, Amanda Branch-Woods, Saumi Mathews, Poonam S. Joshi, Rolen M. Quadros, 
Donald W. Harms, Yan Cheng, Shana M. Miles, Samuel J. Pirruccello, Channabasavaiah B. Gurumurthy, 
Santhi Gorantla, and Larisa Y. Poluektova 
This article is available at DigitalCommons@UNMC: https://digitalcommons.unmc.edu/mmi_articles/4 
RESEARCH ARTICLE Open Access
Human-like NSG mouse glycoproteins
sialylation pattern changes the phenotype
of human lymphocytes and sensitivity to
HIV-1 infection
Raghubendra Singh Dagur1†, Amanda Branch-Woods1†, Saumi Mathews1†, Poonam S. Joshi2†, Rolen M. Quadros2,
Donald W. Harms2, Yan Cheng1, Shana M. Miles3, Samuel J. Pirruccello4, Channabasavaiah B. Gurumurthy2,5,
Santhi Gorantla1 and Larisa Y. Poluektova1*
Abstract
Background: The use of immunodeficient mice transplanted with human hematopoietic stem cells is an accepted
approach to study human-specific infectious diseases such as HIV-1 and to investigate multiple aspects of human
immune system development. However, mouse and human are different in sialylation patterns of proteins due to
evolutionary mutations of the CMP-N-acetylneuraminic acid hydroxylase (CMAH) gene that prevent formation of
N-glycolylneuraminic acid from N-acetylneuraminic acid. How changes in the mouse glycoproteins’ chemistry affect
phenotype and function of transplanted human hematopoietic stem cells and mature human immune cells in the
course of HIV-1 infection are not known.
Results: We mutated mouse CMAH in the NOD/scid-IL2Rγc
−/− (NSG) mouse strain, which is widely used for the
transplantation of human cells, using the CRISPR/Cas9 system. The new strain provides a better environment for
human immune cells. Transplantation of human hematopoietic stem cells leads to broad B cells repertoire, higher
sensitivity to HIV-1 infection, and enhanced proliferation of transplanted peripheral blood lymphocytes. The mice
showed no effect on the clearance of human immunoglobulins and enhanced transduction efficiency of recombinant
adeno-associated viral vector rAAV2/DJ8.
Conclusion: NSG-cmah−/− mice expand the mouse models suitable for human cells transplantation, and this new
model has advantages in generating a human B cell repertoire. This strain is suitable to study different aspects of the
human immune system development, provide advantages in patient-derived tissue and cell transplantation, and could
allow studies of viral vectors and infectious agents that are sensitive to human-like sialylation of mouse glycoproteins.
Keywords: CMP-N-acetylneuraminic acid hydroxylase, NOD/scid-IL2Rγc
−/− mice, Hematopoietic stem cells, HIV-1
Background
All vertebrate cell surfaces display a dense glycan layer
often terminated with sialic acids that have multiple
functions due to their location and diverse modifica-
tions [1]. The major sialic acids in most mammalian
tissues are N-acetylneuraminic acid (Neu5Ac) and N-
glycolylneuraminic acid (Neu5Gc), the latter being derived
from Neu5Ac via addition of one oxygen atom by CMP-
Neu5Ac hydroxylase (Cmah). The pattern of proteins
glycosylation affects the physiology of the cell, cell-to-cell
communication, adhesion, migration, recognition by other
cells and antibodies [2]. In infectious diseases, sialylation
patterns influence how humans interact with some patho-
gens or viral vectors including HIV-1, malaria, influenza,
and streptococcus [3–13]. In xenotransplantation and
stem cell biology, it is a key factor for graft acceptance and
preservation of self-renewing properties [14]. Of the two
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most common sialic acids forms Neu5Gc is widely
expressed on most mammalian tissues but has limited
accumulation in human cells [15]. The human deficiency
of Neu5Gc is explained by an inactivating mutation in the
gene encoding CMP-N-acetylneuraminic acid hydroxylase
(CMAH), the rate-limiting enzyme in generating Neu5Gc
in cells of other mammals [16]. This deficiency also results
in an excess of the precursor Neu5Ac in humans. This mu-
tation appears universal to modern humans and happens
to be one of the first known human-great ape genetic dif-
ferences with an obvious biochemical readout. In particu-
lar, it is important for interaction with Sialic acid–binding
Ig-like lectins, or Siglecs. Expression of such lectins vary in
their specificity for sialic acid–containing ligands and
are mainly expressed by cells of the immune system.
For example, humans, compared to mice and rats, express
a much larger set of CD33rSiglecs [17]. CD33rSiglecs have
immune receptor, tyrosine-based inhibitory motifs, and
signal negatively [18]. Interaction with Siglec-7 has the
potential to also affect monocyte migration and function
[19] along with T-cell activation [8, 20, 21]. During B cells
activation and germinal center formation (GC), Siglecs
are important for appropriate activation of B cells and
responses to T-cell-dependent and independent anti-
gens [22]. In B-cell antigen receptor (BCR) engagement,
interaction of CD22 and Siglec-G has been shown to
inhibit the BCR signal [23]. Most importantly, exposure
to exogenous Neu5Gc is known to cause rapid phosphor-
ylation of beta-catenin in both CMAH-overexpressing
cells and bone marrow-derived mesenchymal stem cells,
thereby inactivating Wnt/β-catenin signaling and, as a
consequence, possibly forcing stem cells to lose pluri-
or multipotency [24].
Immunodeficient mice transplanted with human
hematopoietic stem/progenitor cells (HSPC) are an
established model to study human-specific infections like
HIV-1 [25]. However, if a particular sialic acid residue is
missing in a donor species (Neu5Gc) and present in the
recipient, biologic consequences can be difficult to delin-
eate. Exclusion of mouse Neu5Gc has the potential to im-
prove immune responses to pathogens with non-human
patterns of glycosylation like HIV-1 and HCV (hepatitis
C virus) and to study the pathogenicity of human-like
sialylated pathogen surfaces [12, 17, 26, 27].
To distinguish the effect of the expression of CMP-N-
acetylneuraminic acid hydroxylase in mice on human HSPC
biology, improve the development of a human immune
system in mice, and study responses to HIV-1 infection, we
generated mutation in exon 6 of the gene on NSG strain
using CRISP/Cas9 technology [28]. We compared original
NSG and NSG-cmah−/− strains for multiple parameters and
observed changes in the human lymphocyte phenotype and
repertoire. Human lymphocytes generated from HSPC in a
human-like sialylation environment exhibit persistence of
naïve non-activated T-cell phenotypes and are more
sensitive to HIV-1 mediated depletion of CD4+ T-cells.
Alternatively, mature human lymphocytes derived from
human peripheral blood expand more efficiently in the
NSG-cmah−/− mice with higher levels of activation.
This new strain expands the utility of the NSG standard
strain used to study human hematopoiesis and immunity
and allows comparison of new viral vectors for gene ther-
apy and sensitivity to a wider variety of pathogens.
Results
Generation of NSG-cmah−/− mice
To generate a Cmah knockout mouse on NSG background,
we designed two single guide RNAs (sgRNAs) targeting
exon 6. Schematic of CRISPR targeting are shown in Fig. 1.
Embryo isolation, microinjection, and generation of founder
mice were performed as described in Harms et al. [28].
Among the three live born offspring, one contained mixture
of PCR banding pattern suggestive of gene editing at the
locus. This founder mouse was bred to NSG strain (Jax
stock number 005557). Some of the F1 offspring animals
contained two bands (one corresponding to the wild type
size, and a shorter second band). The shorter band was
sequenced, which revealed a deletion of 27 bases in the
target site (one nucleotide in intron 5–6 and the remaining
26 nucleotides in the exon 6) Fig. 1b and c. This allele was
then maintained in NSG strain (Jax stock number 005557)
to establish the Cmah− colony (Fig. 1d). The NSG-cmah−/−
mice are available from The Jackson Laboratory
as NOD.Cg-Cmahem1Guru Prkdcscid Il2rgtm1Wjl/GuruJ
(https://www.jax.org/strain/031900)
NSG-cmah−/− phenotype
To confirm the inactivation of CMAH gene enzymatic
activity and the absence of hydrolysis of Neu5Ac to
Neu5Gc, we used the chicken anti-Neu5Gc antibody
and anti-chicken immunoglobulin Y (IgY) antibody in
different formats: horseradish peroxidase (HRP)-conju-
gated for Western blot (WB) and immunohistochemistry
(IHC) of paraffin-embedded sections (Fig. 2a and b).
FITC-conjugated antibodies were used for analysis of the
surface expression Neu5Gc on immune cells in the per-
ipheral blood (Fig. 2c and d). Neu5Gc expression was
undetectable by WB and IHC in all tested tissues: spleen,
liver, lung, kidney, heart, gut, and brain. The results were
comparable with existing C57Bl/6-Cmah−/− animals. More-
over, flow cytometry showed better reduction of Neu5Gc
expression on immune cells of NSG-cmah−/− mice than on
the existing strain of immune competent animals. By these
three techniques, we confirmed the absence of CMAH gene
activity and a human-like sialylation pattern of mouse bio-
molecules. Breeding for two years did not reveal any differ-
ences in fertility, body weight, or life span in comparison to
the founder NSG mice. Observation up to 9months of age
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of humanized mice did not reveal increased incidence of
graft-versus-host disease or anemia compared to humanized
NSG mice.
Comparison of human immune system development after
CD34+ hematopoietic stem/progenitor cell
transplantation
Another wide application of NSG mice is transplantation
of human CD34+ HSPC for the development of human
lymphopoiesis [29, 30]. The establishment of human
B-cell lymphopoiesis in mouse bone marrow and T-cell
lymphocytes in mouse thymus has been well demon-
strated [29]. In this model, the expansion of human B
cells occurs significantly earlier than CD3+ T cells. We
tested whether differences in cell surface glycoproteins
sialylation would affect activation of newly generated
human lymphocytes. NSG-cmah−/− and wild-type (wt)
NSG mice were transplanted at birth with the same donor
HSPC (n = 10–12 per strain). At 3 and 6months post-
transplantation, the proportion of human T and B cells, as
well as activation status, was determined (Fig. 3). The
following markers were used: CD45RA for naïve CD3+ T
cells and CD22 for CD19+ B cells. CD22 is a BCR
co-receptor that regulates B cell signaling [31], prolifera-
tion, and survival; it is required for T cell-independent
antibody responses [32]. The frequency of human T cells
in the peripheral blood of 3-month-old mice was higher in
NSG wt mice, and the proportion of circulating B cells
at the same time was higher in NSG-cmah−/− mice. By
6 months of age, there were similar proportions of T
and B cells in the peripheral blood (Fig. 3c) regardless
of sialytion status. In both strains the proportion of CD4+
cells in peripheral blood increased. NSG and NSG-cmah−/−
mice at this time had similar proportions of naïve
CD3+CD45RA+ cells, which declined with time. Human B
cells in NSG-cmah−/− mice showed a lower number of
activated CD19+CD22+ cells at 3months of age. The differ-
ences in B cell activation (CD22 expression levels) were
sustained at 6 months post-engraftment. The propor-
tion of CD19+IgD+ B cells was lower in NSG-cmah−/−
mice at 3 months and did not decline by 6 months as
was found in NSG wt humanized mice. The proportion
of CD19+IgM+IgD+ B cells in peripheral blood of both
strains declined, and the proportion of CD19+IgM−IgD+
cells [33, 34] increased. We did not observe significant
differences in the numbers of CD19+IgM+IgD− mature B
cells between strains at 6months (5.9 ± 0.9% and 7.7 ±
1.3% NSG-cmah−/− and NSG, respectively). The low levels
of CD19+IgG+ (0.7–3.8%, not shown) cells were found in
both strains. The levels of IgM at 6months of age varied
from 1 to 350 μg/ml (Fig. 3c) and only low levels of IgG
(1–50 μg/ml, not shown) were present in both strains at
6 months of age.
Analysis of T and B cell repertoires in NSG-cmah and wild
type NSG mice
To characterize the global B and T cells receptor reper-
toires, we selected non-fractionated bone marrow cells
suspension and spleen tissue samples. Human-specific
primers were selected for analysis of human cells according
to Adaptive Biotechnologies® (Seattle, WA, USA) technology
[35]. We compared the repertoire profiles of bone marrow
and spleen within one mouse and between NSG-cmah−/−
and wt NSG mice. The generation of mature human lym-
phocytes requires a complex selection process in bone mar-
row (B cells) and thymus (T cells) and is highly dependent
on the microenvironment. Glycosylation of stromal mouse
counter-receptors is important for pre-B cells signaling and
Fig. 1 Disruption of Cmah gene in NSG strain mouse using the CRISPR/Cas9 system. a Schematic of CRISPR sgRNA guides to disrupt Exon 6 of
CMAH gene. b Sequence alignment of the wild type and the deletion allele. The guide sequences are shown in red and the protospacer
adjacent motif (PAM) sequences are in green. c The founder number 2, containing a prominent deletion band, was bred to segregate the mutant
allele. Genotyping PCR of F1 mice showing mixture of wild type (line 2 and 6) and with the deletion bands (1, 3, 4, 5). d Genotyping of the
homogygous NSG-cmah−/− line established after 4 generations of breeding of the founder #2 (n = 10)
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proliferation [36] and retention in bone marrow for B cells
[37]. Maturation and activation of human B and T cells in
mouse primary (bone marrow and thymus) and secondary
lymphoid organs (spleen, lymph nodes) will likely affect B
and T cell receptors repertoire and development [38]. Using
the same donor of HSPC, we compared the B and T cell
receptors repertoires in the new and existing NSG strain at
8months of age. Spleen tissue and bone marrow pelleted
cells were used for genomic DNA (gDNA) extraction with
immunosequencing provided by Adaptive Biotechnologies®.
Collected data were analyzed using immunoSEQ Analyzer
(https://www.adaptivebiotech.com/). We used the common
indexes to determine diversity of repertoires based on DNA
sequences of the rearranged V-D-J gene segments encoding
the third complementarity-determining region (CDR3) of
IgH loci and T cell receptor beta chain (TCRβ) in a given
sample, the length of CDR3, and usage of IgH and TCRβ
genes (Fig. 4 and Additional files 1, 2, 3, 4 and 5: Figure S1,
S2, S3, S4 and S5).
Gaussian-like distribution patterns of IgH CDR3 length
in NSG-cmah−/− mice were similar to wt NSG (Fig. 4a,
and b) mice. In contrast, the frequency of clonal B-cell
expansion was more common in the wt NSG mice, and
the difference was close to statistical significance. A simi-
lar size distribution pattern of IgH CDR3 length was
observed in bone marrow samples evaluated for five
NSG-cmah−/− mice. The NSG animals analyzed also had
significant variability (Additional file 1: Figure S1b, two
animals). The variability in NSG mice was also reflected
by variable total number of templates (Additional file 1:
Fig. 2 NSG-cmah−/− mice phenotype. aWestern blot analysis of Neu5Gc
presence in NSG wild type mice (cmah+) and NSG-cmah−/− (cmah-) tissue
samples. All tested mouse tissues with chicken anti-Neu5Gc antibody
(Biolegend, CA, USA, 1:4000) were negative. b Confirmation of CMAH
knockout on NSG background by immunohistology. Spleen, kidney, and
lung tissues were fixed, paraffin embedded and 5μ thick sections of
NSG-Cmah−/− generated strain (left), wt NSG (right) mouse and
Cmah−/-C57/Bl6 original immune competent strain (middle column) were
stained with antibodies for Neu5Gc (anti-Neu5Gc antibody, Biolegend, CA,
USA, 1:100) at 4 °C overnight. Images captured by Nikon E800 microscope
at objective magnification 20×. New generated strain-derived
tissues deficient for Neu5Gc as existing cmah−/-C57/Bl6 strain. Wt
NSG mice express Neu5Gc epitopes, and tissue sections have
brown color. c Confirmation of CMAH gene knockout on NSG
background by FACS. We compared expression of Neu5Gc on
white blood cells by staining with anti-Neu5Gc antibody and
secondary FITC-labeled anti-chicken reagent. Panel shows Neu5Gc
staining for C57Bl/6 cmah−/− original strain obtained from the
Jackson Laboratories (Stock No: 017588) (red) compare to C57Bl/6
wild type (orange). d Panel shows the similar pattern of the
absence of Neu5Gc expression on NSG-cmah−/− mice (cyan) and
the presence of Neu5Gc on cells derived from heterozygous mice
that retain enzyme activity and have Neu5Gc on the surface of
leucocytes (green and red). c, d Individual samples of a mean
fluorescence intensity (left panels) and mean ± SEM are shown for
each group of mice (n = 6, right panels)
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Figure S1e). We observed lower diversity of B cell reper-
toires in NSG mice compared to NSG-cmah−/− strain ac-
cording to higher clonality of IgH genes in bone marrow
and spleen (Fig. 4c and Additional file 1: Figure S1c). The
average IgH CDR3 length naturally generated by the
rearrangement machinery was found to be reduced during
B cell development, and we observed a slight shift to the
left of CDR3 length in 4 of 5 analyzed NSG-cmah−/− mice
by comparing bone marrow and spleen compartments
(Additional file 2: Figure S2). The use of IgH genes families
was similar in spleen and bone marrow (Additional file 3:
Figure S3C) and correspond to the known human
Fig. 3 Effects of the cmah−/− background on human immune cells expansion and activation after HSPC transplantation. At 3 and 6months post
CD34+ cell transplantation, the frequency of circulating human lymphocyte subsets were analyzed. a and b Representative plots and gating
strategies for human B-cell and T-cell enumeration. c Individual mouse NSG-cmah−/− (open symbol, n = 11) and NSG wild type mice (closed
symbol, n = 10) and means with SEM are shown for human B and T cells in mouse peripheral blood. Naïve phenotype of CD3+CD45RA+ T-cells
exhibited better persistence at 6 months of age in the NSG-cmah−/− strain. Lower proportions of mature CD19+IgD+ B cells in peripheral blood
of cmah−/− mice at 6 months of age, as well as a lower frequency of CD22 B-cell expression at 3 and 6months of age, were also observed. P values
were determined with Kruskal-Wallis test and Dunn’s multiple comparisons tests (*) P values determined by Mann-Whitney test (#), and paired t-test
(@) are shown
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peripheral blood B cell data [38, 39]. We observed similar
changes in IgH D and J gene family usage between bone
marrow (pre- and immature B cells) and spleen compart-
ment with mature B cells (Additional file 3: Figure S3C).
The clonality of IgH gene loci were two folds higher in
spleen compared to bone marrow, and in cmah−/− mice
reached statistical significance (Fig. 4d).
We did not observe significant differences in TCRβ
chain gene usage (Additional file 4: Figure S4) nor rep-
ertoires in new strain compared to NSG mice (Add-
itional file 5: Figure S5). TCRβ clonality was lower in
spleen compared to bone marrow in both strains, but
these changes did not reach statistical significance
(Additional file 5: Figure S5b). The richness of
repertoire was higher in spleen tissues compared to
bone marrow samples in both strains (Fig. 5d). We did
not observe statistically significant differences in
TCRβ CDR3 length (Additional file 5: Figure S5a, and
b) in spleen and bone marrow (not shown). Overall
CDR3 length (nucleotides) was shorter in T cells com-
pared to B cells. We did not find statistically signifi-
cant differences in samples clonality and noted higher
TCRβ richness in spleen compared to bone marrow as
total number of TCRβ chain gene templates. Addition-
ally, we observed better Pielou’s evenness of TCRβ in
NSG cmah−/− mice and overall increased evenness in
spleen compared to bone marrow compartment (Add-
itional file 5: Figure S5c, d, and e).
Fig. 4 Effects of the NSG-cmah−/− background on human immune cells IGH genes repertoires. a Histograms of IgH CDR3 length (nucleotides) in
spleen of NSG-cmah−/− and b NSG mice. c NSG-cmah−/− background was associated with a lower frequency of clonal B-cell expansion in spleen. d After
transition from bone marrow to spleen, clonal B-cell expansion increased in NSG- cmah−/− mice. Statistical analysis of CDR3 length was performed
immunoSEQ Analyzer (https://www.adaptivebiotech.com/). P< 0.05 was considered a statistically significant. Five animals per strain were used. Individual
CDR3 length in spleen (mature compartment) and bone marrow (developmental compartment) are shown on Additional file 2: Figure S2.
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Comparison of human immune system responses to HIV-1
infection in NSG-cmah−/− and wt NSG mice
NSG mice, humanized by human hematopoietic stem cell
transplantation, are a proven model to study the
pathogenesis of HIV-1 infection [39]. We evaluated the ef-
fects of human-like sialylation of mouse tissues on the
sensitivity of human cells to HIV-1. Two groups of
mice with similar levels of reconstitution of circulating
Fig. 5 Effects of the cmah−/− background on human cell responses to HIV-1 infection. NSG-cmah−/− and NSG wt mice were infected with HIV-1ADA
intraperitoneally at 6 months of age. a At 4 weeks post infection, blood samples were collected for FACS analyses of the peripheral blood. The
absolute numbers of human CD45+ cells in peripheral blood were similar: cmah−/− control 38.5 ± 10.4 cells/μl (n = 12); cmah−/− HIV+ 35.6 ± 9.6 cells/μl
(n = 16); NSG control 30.6 ± 6.5 cells/μl (n = 10); NSG HIV+ 28.7 ± 9.0 cells/μl (n = 14). b Four to seven animals per group were euthanized for the spleen
profile analysis. Bone marrow data shown on Fig. 6. FACS gating strategies were used: human CD45/CD3/CD19; CD3/CD4/CD8. For available blood
samples, additional analyses for human cells subpopulations CD4/CD45RA/CD45RO/CD62L/CCR7 were done. For spleen, additional analyses included:
human CD45/CD14/CD123/CD1c. Available plasma samples were analyzed for the HIV-1 RNA copies number, human IgM, IgG and HIV-1
specific antibodies at 1:10 times dilution (last panel a Individual mouse and means with SEM are shown. P values were determined with
Kruskal-Wallis test and Dunn’s multiple comparisons tests (*) and Mann-Whitney test (#). P ≤ 0.05 were considered significant. Viral load at
4 weeks post infection was compared with unpaired t test with Welch’s correction. In comparison to NSG mice, NSG-cmah−/− mice showed a
higher sensitivity to HIV-1 infection with increased viral load at 4 weeks post infection and a significant decrease in numbers of CD4+ T cells
including effector CD4+CD45RO+CD62L−CCCR7− cells post-infection. Profiling results of animals euthanized at 9 weeks post-infection are
shown in Additional file 7: Figure S7.
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human CD45+ cells in peripheral blood were infected with
the same dose of HIV-1ADA (macrophage tropic CCR5 co-
receptor using strain) intraperitoneally at the age of 30–
32 weeks when the majority of peripheral human cells
were CD3+CD45RO+−T cells. Four weeks post-infection,
peripheral blood, spleen, and bone marrow samples
were analyzed (Figs. 5 and 6, Additional files 6 and 7,
Figure S6, S7). We observed a significant reduction in
human T cells in all three compartments in NSG-cmah−/−
mice including both CD3+ and CD3+CD4+ T-cells. The
percentage of CD4+CD45RO+ cells and among this
antigen-stimulated cells proportion of CD4+CD45RO+
CD62L−CCR7− effector memory cells, the most sensitive
to HIV-1 depletion, decline in cmah−/− mice compared to
unaffected. The result was an increased frequency of
central memory T cells CD4+CD45RO+CD62L+CCR7+ in
the peripheral blood and spleen of HIV-1 infected mice.
This effect was not observed in NSG mice peripheral
blood and spleen compartment. We found a higher HIV-1
viral load (VL) in the peripheral blood of NSG-cmah−/−
mice at 4 weeks post-infection. In both strains, VL persisted
at high levels for up to 9weeks post-infection. As T cells
decreased, we observed an increased frequency of B cells in
all three compartments (blood, spleen, bone marrow). We
also noted an increased proportion of human CD1c+
cells in spleen of infected NSG-cmah−/− mice compared
to wt NSG. Corresponding increases in myeloblasts
(CD34+CD117+), promonocytes (CD4dimCD14neg or dim),
and mature monocytes (CD4dimCD14bright) in bone mar-
row of HIV-1 infected NSG-cmah−/− mice were observed
(Fig. 6c). We did not observe any differences in natural
killer (NK) and NKT cells subpopulations (not shown)
between the two strains. We also did not find differences
in the levels of immune globulins and circulating HIV-1
specific binding antibodies. At nine weeks post-infection,
in peripheral blood of HIV-1 infected NSG-cmah−/− mice,
the decreased proportion of CD3+ cells and specifically
CD4+CD45RO+ effector memory cells with increased
number of monocytes CD14+ were found (Additional file 7:
Figure S7).
Effects of NSG-cmah−/− phenotype on transplanted
human peripheral blood mononuclear cells behavior
NSG mice are widely used for the transplantation of
human peripheral blood immune cells (PBMC) [40]. We
considered that the absence of Neu5Gc and human-like
sialylation of glycoproteins could change the behavior of
mature human immune cells derived from the adult donor.
Fig. 6 Effects of the cmah−/− background on human cell responses to HIV-1 infection in bone marrow. a Human differentiated T cells, b precursors
and mature B cells, c myeloid lineage cells FACS analyses. Mice bone marrow were reconstituted with comparable proportions of human CD45+ cells;
HIV-1 mediated depletion of T cells was more pronounced in NSG-cmah−/− animals compared to NSG wt (n = 4–5). HIV-1 infection increased
the relative proportion of B cell precursors and mature B-cells (CD20+) and the proportion of CD14+ macrophages compared to NSG mice.
Individual mouse and means with SEM are shown. P values were determined with Kruskal-Wallis test and Dunn’s multiple comparisons tests
(*) and Mann-Whitney test (#). P ≤ 0.05 were considered significant. The gating strategies are shown in Additional file 6: Figure S6.
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PBMC isolated from one donor were transplanted into the
NSG and NSG-cmah−/− mice intraperitoneally (six males
per group). Starting from day 7 post-transplantation, mouse
peripheral blood was collected and stained for the presence
of human immune cells (Fig. 7). Human T lymphocytes
were the major population with low absolute number of B
cells and monocytes in peripheral blood. The expansion of
human cells in NSG-cmah−/− mice significantly (~ 2–3.5
Fig. 7 Human immune cells expansion and phenotype changes in NSG-cmah−/− mice. Males NSG-cmah−/− and wt NSG 5 weeks of age were
transplanted intraperitoneally with single-donor human peripheral blood mononuclear cells. The number and phenotype of human cells in
peripheral blood were analyzed up to 31 days post transplantation and percentage of human cells in the spleen at the end point of observation.
a Gating strategy to identify human CD45+ cells, CD19+, CD14+, and CD3+ T cells and their subpopulations. b Absolute counts of human cells in
peripheral blood with accelerated expansion of human T cells and CD4+ cells in the NSG-cmah−/− compared to NSG. c Proportion of human
cells in the spleens at the end-point were similar in both strains. d Proportion of memory CD45RO+ and central memory CD45RO+CD62L+ were
increased in NSG-cmah−/− mice among CD4+ T-cells in blood and spleen. e Proportion of CD8+ T-cells were also increased but to a lesser degree. Six
animals per group (males) were used and b and d represent means with SEM, c and e individual mouse data. Statistical analysis done by 2-way
ANOVA with Sidak’s multiple comparison test, * - P < 0.05
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times) exceeded that seen in the NSG mice, and the abso-
lute count of human CD45+ cells (mean ± SEM) were 16 ±
2 vs 9 ± 1 cells/μl at day 7, 513 ± 135 vs 146 ± 58 cells/μl at
day 14, 474 ± 130 vs 168 ± 118 at day 21 (P < 0.05) (Fig. 7b).
The proportion of human cells in spleen were similar at the
end-point of observation (Fig. 7c). Human T-cells in the
mouse environment became activated and switched expres-
sion of CD45RA (naïve) to CD45RO (effector-memory).
The activation of CD4+ cells in Cmah−/− mice significantly
exceeded the CD45RO to CD45RA switch in wt NSG mice.
To a lower extent, the same was observed within CD8+
T-cells (Fig. 7d). L-selectin (CD62L) is an adhesion
molecule that recognizes sialylated carbohydrate groups,
mediates the first steps of leukocyte homing to peripheral
lymph nodes, and is programmed for recirculation through
lymphoid organs, thus, crucially controlling the initiation
and maintenance of immune responses to pathogens [41].
CD62L+ T-cells also were generated at higher frequency in
Cmah−/− mice, including the splenic population of CD4+
CD45RO+CD62L+ (Fig. 7e). Overall, for this particular
donor, engraftment and expansion of mature human
peripheral blood lymphocytes were more pronounced
in the NSG-cmah−/− mouse strain.
Host glycoproteins sialylation pattern affects the
clearance of HIV-1 virus, rAAV2/DJ8 biodistribution but
not half-life of infused human IgG
There is evidence that evolutionary loss via mutation of
the CMAH genes changed the sensitivity of humans to
viral and bacterial pathogens [42, 43]. We investigated
the life-span of the HIV-1 virus in the two mouse strains
since the mouse is not a normal permissive host. We
tested the concentration and time of HIV-1 VL in the
peripheral blood of the non-humanized mouse as a param-
eter that potentially could influence viral pathogenicity. On
the first and second day after intraperitoneally injection of
0.3ml of HIV-1ADA viral stock, the detected copy numbers
of HIV RNA were lower by ~ 0.3 log10 in NSG-cmah
−/−
mice compared to NSG [4.98 ± 0.1 and 4.1. ± 0.08 com-
pared to 5.25. ± 0.06 and 4.4 ± 0.05 log10, respectively
(P < 0.05, Fig. 8a)].
The clearance of sialylated glycoproteins going through
the multiple types of receptors and changes of mouse
sialylation could affect interaction with human immune
globulins. We compared the time of circulation of human
IgG in NSG-cmah−/− and wt mice (Fig. 8b). We were not
able to determine the first minutes of injected IgG dose
clearance, but overall clearance of human IgG was nearly
identical in the two strains of mice. A slightly higher
concentration remained in NSG-cmah−/− mice compared
to NSG at the end of observation (1.1 ± 0.04 and 0.9 ±
0.03 μg/ml for NSG-cmah−/− and wt mice, respectively).
Biodistribution and expression levels of recombinant
adeno-associated virus (rAAV) vector delivered genes could
be affected by sialylation of host receptors [5, 10, 44]. We
compared the luciferase expression delivered by rAAV2/
DJ8. We were not able to detect statistically significant
differences in luminescence in liver and spleen between the
two strains at 7, 14, and 21 days post-inoculation (data
not shown). However, at 32 days the expression of
luciferase RNA was significantly higher in the spleen
and brain of NSG-cmah−/− as determined by ddPCR
(Fig. 8c). It was higher by 0.60 log10 copies in spleen
(4.72 ± 0.12 vs 4.12. ± 0.07 log10) and 0.54 log10 in
brain (1.40 ± 0.11 vs 0.85. ± 0.12 log10) of cmah
−/− mice
compared to NSG (P < 0.05).
Discussion
We created NSG-cmah−/− mice with the intent to use this
strain for different aspects of biomedical research. As initial
phenotypic characterization, we compared several parame-
ters involved in human immune system development in
NSG-cmah−/− to the parent NSG strain. Glycoprotein-lec-
tin interactions (for example, hematopoetic cells surface
glycoporteins – bone marrow stromal cell lectins/selectins)
are an important mechanism of human B-cell selection.
Fig. 8 Effects of cmah−/− background on HIV-1 and IgG clearance from blood circulation and tissue luciferase expression delivered by rAAV2/DJ8.
a Clearance of HIV-1 from mouse peripheral blood. b Clearance of human IgG from the peripheral blood (n = 5). Percentage of human IgG
determined at 30 min after injection of 100 μl of a 10% human IgG (10 mg/mouse) were 10.6 ± 1.2 and 11.0 ± 0.9 μg/ml for NSG-cmah−/− and
wild type mice, respectively. Five to three blood samples were collected for days 1–14 time points, mean and SEM are shown. End-point IgG
concentrations in peripheral blood were 1.1 ± 0.04 and 0.9 ± 0.03 μg/ml for NSG-cmah−/− and wild type mice, respectively. c Luciferase RNA
expression at 32 days post intravenous injection in liver, spleen, and brain of NSG-cmah−/− (n = 5) and wild type mice (n = 5). (#) P ≤ 0.05 were
considered significant by two-tail Mann-Whitney test
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The NSG mouse environment that contained Neu5Gc
(non-human type of sialylation) exhibited a higher fre-
quency of clonal B-cell outgrowth that may represent
responses against the Neu5Gc moiety. In the absence of
Neu5Gc, human B cells appear to remain less activated.
This finding indicates that non-human sialylation has a
negative effect on human B cell development, and the
NSG-cmah−/−strain provides a more supportive environ-
ment with good repertoire development and less clonal out-
growth [45]. The observations of lower IgD+ and CD22+
human B cells and sustained naïve CD45RA+CD3+ cells in
the NSG-cmah−/− strain also support this conclusion.
We observed better bone marrow B-cell precursor
engraftment in control NSG mice compared to NSG-
cmah−/−, and better bone marrow T-cell engraftment in
NSG-cmah−/−. The HIV-1 infected NSG-cmah−/− mice
showed a significant reduction in bone marrow T-cells
and a subsequent increase in bone marrow B-cell pre-
cursor engraftment. These findings may indicate T-cell
suppression of B-cell engraftment is occurring in this
mouse strain but will require further study to confirm.
In contrast, the NSG strain showed similar levels of
bone marrow T-cell and B-cell engraftment regardless
of infection with HIV-1.
The T cell TCRβ chain repertoires in NSG-cmah−/− and
wt NSG mice were not different in clonality metrics and
remain polyclonal in bone marrow and spleen. However,
compared to wt NSG mice, NSG-cmah−/− exhibited better
evenness of repertoire between spleen and bone marrow.
We did not observe statistically significant differences in
clonal T-cell expansion based on TCRβ CDR3 length fre-
quency in bone marrow versus spleen. This was previously
reported for NOD/scid mice transplanted with cord blood
derived hematopoietic CD34+ stem cells [46].
In the studies presented here, we are not showing
effects of vaccination with the childhood vaccines DTaP,
HiB, and MMRII, which were tested in comparison on
both strains of humanized mice at 6months of age. Only a
few animals developed antigen-specific IgM. The inability
of CD34-NSG humanized mice to efficiently respond to
vaccination is related to multiple deficiencies recognized in
the humanized animals. This includes the absence of
supportive cytokines, human follicular dendritic cells
responsible for accumulation of antigen and stimulation
of germinal center B-cells, deficiency of follicular helper
cells involved in T-cell dependent immune responses,
deficiency of complement, and others (reviewed in [47]).
Several approaches to improve human adaptive immune
responses were explored by elimination of mouse tissue
histocompatibility antigens and introducing human MHC
class I and II, cytokines and co-transplantation of bone,
spleen, liver, and thymus. These approaches improved
adaptive responses to varying degrees. It is possible that
the introduction of these additional factors on the NSG-
cmah−/− background will further optimize the function of
the human immune system and development of adaptive
immune responses.
In addition to the comparison of human immune system
cell development and phenotype, we assessed the behavior
of human mature peripheral blood mononuclear cells in
their ability to colonize mouse spleen and peripheral blood.
In contrast to lymphocytes generated from human stem
cells transplanted into NSG-cmah−/− mice, which showed
reduced levels of activation, transplanted mature lympho-
cytes very quickly expand and lose the naïve CD45RA+
phenotype. This could be attributed to the selection of
human T cells in mouse thymus and reduced respon-
siveness to the mouse MHC (major histocompatibility)
antigens.
Sialic acid on cellular membrane molecules has been
identified as an attachment receptor for several pathogens
and toxins. The composition could influence the viral
capture by different cell types and trans-infection [48].
We observed increased HIV-1 mediated depletion of
human CD4+ T-cells in the NSG-cmah−/− strain of mice
compared to the parental NSG. We also found a reduction
of circulating HIV-1 RNA in non-engrafted NSG-cmah−/−
mice suggesting the viral particles may be more efficiently
absorbed by cells with human-like sialylation patterns. We
previously showed that mice transplanted with human
hepatocytes also had enhanced clearance of virus from the
circulation [49]. The increased pathogenicity of HIV-1 in
NSG-cmah−/− mice may be related to both the properties
of human cells raised in the more human-like modified
mouse environment as well as interaction of virus with
the modified mouse stroma.
As humanized mice serve as a model to test biologic
activity of human therapeutic antibodies [50, 51], we
compared the clearance of human IgG. Human IgG
contain oligosaccharides with N-acetylneuraminic acid
(Neu5Ac, NANA); whereas, rhesus, cow, sheep, goat,
horse, and mouse IgGs contain oligosaccharides with
N-glycolylneuraminic acid (Neu5Gc, NGNA). The asia-
loglycoprotein receptor on hepatocytes [52] and FcRn
on endothelial cells and placenta [53] could potentially be
affected by human-like sialylation of receptors. Human
FcRn binds to human, rabbit, and guinea pig IgG, but not
significantly to rat, bovine, sheep, or mouse IgG (with the
exception of weak binding to mouse IgG2b). In contrast,
mouse FcRn binds to all IgG as previously analyzed [53].
Our expectation was not confirmed, and the clearance
of human Intravenous immunoglobulin (IVIG) injected
intravenously in NSG-cmah−/− mice was not statisti-
cally different. It is possible that purified from blood
donor serum IgG with the sialylated fraction contributing
about 10% of the total IgGs was not the appropriate
reagent for comparison. Future studies with known pre-
cise Neu5Ac content in the Fc region of IgG will help to
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understand applicability of the model [54]. Another mis-
cellaneous application of NSG-cmah−/− mice could be
testing the transduction efficacy of viral vectors as well as
viruses [55]. We used a common vector of rAAV serotype
2 with luciferase and expected to see the differences of
transduction efficacy between wt NSG and NSG-cmah−/−
mice. We found the expression of luciferase was not
different in liver (the major affected organ), but we did
observe differences in less commonly affected organs,
such as spleen and brain. These findings suggest that
endothelial and splenic hematopoietic cells with human-
like sialylation profiles could be more sensitive to viral
infection.
Conclusions
Humanized mice are widely used to study the human
immune system responses to pathogens and therapeu-
tics. However, mouse specific glycosylation affects the
development of the human immune system and responses
to various agents, such as viruses or biological, human-
specific products like antibodies. We demonstrated that
human-specific sialylation established by mutation of the
CMAH gene supports naïve B and T cell generation with
polyclonal receptors repertoires. In contrast to NSG wild
type mouse sialylation background, we found the NSG-
cmah−/−background increased sensitivity to HIV-1 infec-
tion and influenced rAAV vector transduction patterns.
As such, NSG-cmah−/− mice may accelerate translational




Strains obtained from the Jackson Laboratories C57Bl/
6 (Stock No: 000664), CMAH knock-out (B6.129X1-
Cmahtm1Avrk/J, Stock No: 017588), and NSG (Stock
No:05557) were bred and housed in the pathogen-free
animal facility at the University of Nebraska Medical
Center (Omaha, NE, USA). Mice were housed in indi-
vidually ventilated cages that are changed once every
two weeks within a laminar flow work station using
micro-isolator technique with ClidoxR-S sterilant. All
caging, bedding (cob), and nesting materials were
autoclaved prior to use. Water is R/O filtered, chlorinated,
and supplied by the HydropacR system. Rodent diet used
was autoclaved or irradiated prior to use.
Generation of B6.129X1-Cmahtm1Avrk/J referred here-
after as C57Bl/6-Cmah−/− was described previously [56].
In this mouse, exon 6 was deleted by targeting a cassette
containing LoxP flanked exon 6 with a neomycin cassette
into 129/SvJ derived ES cells, followed by removal of the
exon and the neomycin cassette through Cre enzyme
and injection of deleted clone into blastcysts to generate
chimera. The mice line was backcrossed to C57BL6/J
strain for 10 generations.
CRISPR reagents, mice generation, and genotyping
We deleted exon 6 using CRISPR approach in NSG
strain background. Two guide RNAs were identified to
target part of exon 6 (Cmah gRNA 1 CTTTGTGCA
TTTAACGGACCTGG and Cmah gRNA 2 TGAAATA
TATCAACCCTCCAGGG; PAM sequences underlined
and italicized). The sgRNAs were transcribed from DNA
templates generated by annealing two primers using the
HiScribe™ T7 Quick High Yield RNA Synthesis Kit (New
England Biolabs, Ipswich, MA) following manufacturer’s
instructions. Cas9 mRNA was prepared using the pBGK
plasmid as described in [28]. Injection mixture was
prepared by dilution of the components into injection
buffer (5 mM Tris, 0.1 mM EDTA, pH 7.5) to obtain the
following concentrations: 10 ng/μl Cas9 mRNA, 10 ng/μl
Cmah Left Guide and Right Guide RNA. Female NSG
mice 3–4 weeks of age (JAX Laboratories, Bar Harbor,
ME, USA) were superovulated by intraperitoneal injection
with 2.5 IU pregnant mare serum gonadotropin (National
Hormone & Peptide Program, NIDDK), followed 48 h
later by injection of 2.5 IU human chorionic gonadotropin
(hCG, National Hormone & Peptide Program, NIDDK).
Mouse zygotes were obtained by mating NSG stud males
with superovulated NSG females. The animals were sacri-
ficed using CO2 inhalation followed by cervical dislocation
14 h following hcG administration, and oviducts were
collected to isolate fertilized embryos. Injection mixture
was introduced into the pronuclei and cytoplasm of fertil-
ized NSG embryos by microinjection using a continuous
flow injection mode. Surviving embryos were surgically
implanted into the oviducts of pseudopregnant CD-1
recipient females. Genomic DNAs were extracted from
tail biopsies and genotyping PCRs were performed as
previously reported [28]. Cmah Forward TCCCAGACC
AGGAGGAGTTA and Cmah Reverse TCCACTCCG
AGTTTCAGATCA primers were used for screening by
PCR. The expected amplicon sizes were 455 bases and
428 bases respectively for wild type and mutant mice.
The PCR products were column purified and were
sequenced using the primers used for PCR amplifica-
tion. NSG-cmah−/− mice were bred as homozygous.
Western blot and flow cytometry analyses of NeuGc
expression
Tissue samples from NSG and NSG-cmah−/− mice were
collected and homogenized in ice cold RIPA buffer with
HALT protease inhibitor (cat#78430, ThermoFisher
Scientific, Waltham, MA, USA). Twenty microgram of
protein/sample was denatured in Laemmli sample buffer,
then loaded and ran on a 12% SDS-polyacrylamide gel.
The separated proteins were transferred to polyvinylidene
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difluoride (PVDF) membrane, blocked in 0.5% cold fish
gelatin in TRIS buffered saline with 0.05% Tween-20
(TBS-T) for 2 h at room temperature and then incubated
in the primary antibody, Neu5GC (1:4000 in 0.5% cold
fish gelatin TBS-T; chicken polyclonal IgY antibody,
Biolegend Cat. No 146901) for overnight at 4 °C. After
washes, the membrane was incubated in HRP-conjugated
goat-anti-chicken IgY (GeneTex Cat. GTX26877, Lucerna-
Chem AG, Switzerland) secondary antibody (1:4000) for
1 h at room temperature. The immunoblot was developed
with chemiluminescence and imaged using FluorChem M
imager (Proteinsimple, San Jose, CA, USA). GAPDH was
used as housekeeping control (clone GA1R, cat #MA5–
15738, Thermoscientific, Waltham, MA USA). For flow
cytometry, whole blood was obtained by bleeding the mice
from the facial vein. After spinning it down at 1800 rpm
for 8min and removing the excess serum, 50 μl of the 1:1
mixture of the whole blood and 0.5% gelatin from cold
water fish was incubated in the Fc block for 15min on ice.
Next, the primary anti-Neu5Gc was added and incubated
for 30min on ice. Washing was done by re-suspending
the samples in 1ml of the 0.5% gelatin from cold water
fish and spinning it at 1500 rpm for 5min for 3 times. The
secondary FITC-labeled anti-chicken reagent (ab46969)
staining followed by red blood cells lysis using red blood
cell lysis (Cat. #349202 from BD Bioscience, San Jose,
CA) were performed. Further, acquisition was done on
BD LSR II flow cytometer cells and analyzed on gated
leukocytes using FLOWJO, analysis software (Tree Star,
Ashland, OR, USA).
Immunohistology
Organs collected from NSG-cmah−/−, NSG wt, and
C57Bl/6 mice were fixed and paraffin embedded; 5 μ
thick sections were stained with antibodies for Neu5Gc
(anti-Neu5Gc antibody, Biolegend, San Diego, CA,
USA, Cat. No: 146903, dilution 1:100) at 4 °C overnight.
Secondary anti-chicken antibodies (Biolegend Cat. No.
146901) were used at dilution 1:100 and DAB as
chromogen. Tissues counterstained with hematoxylin.
Human PBMC transplantation and engraftment analyses
NSG-cmah−/− and wild type NSG mice at 8 weeks of age
were transplanted with single donor human PBMC intra-
peritoneally (20 × 106 cells/mouse). Blood samples were
collected by facial vein bleeding for immunophenotyping
at variable intervals (7, 14, 24, 31 days). Five-week post-in-
jection, mice were sacrificed by overdose of isoflurane;
blood, liver, and spleen tissues were collected for immuno-
phenotyping and immunohistochemistry. Briefly, 50 μL of
whole blood was stained in EDTA-coated tubes with two
different monoclonal antibody panels (T cells and B cells)
in a final volume of approximately 100 μl. Cells not stained
with any of the antibody were initially used to define the
gating strategy. Compensation beads (BD Biosciences, cat.
#552843) were stained with each antibody separately and
run at each acquisition to calculate the compensation
matrix. Immunophenotyping was performed to determine
the absolute count and frequency of blood cells: leukocytes
(CD45, BD Biosciences, Cat. #555482); CD3 (#557943);
CD4 (#560650); CD8 (#562428); CD19 (#562653) and
CD14 (eBioscience, San Diego, CA, Cat. #17–0149-42) for
blood and spleen, respectively. The gating strategy for
identification of cell subsets is presented in Fig. 1a. Pres-
ence of activation markers CD45RA/CD45RO (BD Biosci-
ences, #560674; #563215) and CD62L (#555544) was also
checked for CD4+ and CD8+ T cells subpopulations, CD22
on B cells (#563940) in blood and spleen as absolute count
and frequency of parent, respectively. After staining of
cells, red blood cells were lysed with FACS Lysing solution
(BD Biosciences), and cells were washed with phosphate
buffered saline (PBS) and resuspended in 1% paraformalde-
hyde. For absolute counting of the blood samples, Count-
BrightTM absolute counting beads (Invitrogen, Carlsbad,
CA, USA; catalog C36950) were added to each sample be-
fore acquisition. Acquisition of stained cells was performed
on BD LSR II (BD Biosciences) using acquisition software
FACS Diva (BD Biosciences), and data were analyzed using
FLOWJO, analysis software (Tree Star). Event counts of
each cell population were exported, and absolute
count/μl of blood was calculated using the following
formula: [(Number of cell events / number of bead
events) × (assigned bead count of the lot (beads/50 μl) /
Volume of sample)].
Human CD34+ cell transplantation and
engraftment analyses
NSG-cmah−/− and wild type NSG mice reconstituted
with the same cord blood sample derived CD34+ cells
(5 × 104/mouse intrahepatically) were bled at three and
again at 6 months of age. For both time points, ~ 100 μl
of blood was collected into MiniCollect 0.5 mL EDTA
tubes (Greiner Vacuette North America Inc., Monroe,
NC, USA; Cat. #450475). Plasma was collected and
stored at − 80 °C for future use. Remaining cell samples
were diluted at a 1:1 ratio with 50 μl FACS buffer (2%
fetal bovine serum in PBS) and mixed thoroughly. The
samples were divided into two panels, B cell and T cell. The
B cell panel consisted of mouse anti-human CD45-FITC
(BD Pharmingen; Cat. #555482), CD19-BV605 (BD Biosci-
ences; Cat. #562653), CD22 BV421(BD Pharmingen;
#563940), IgG-PerCP/Cy5.5 (Biolegends, # 409312), IgD-PE
(eBiosciences, #12–9868-42), IgM-APC (eBiosciences, #17–
9998-42), and Brilliant Stain Buffer (BD Horizon, #563794)
cocktails. The T cell panel consisted of: anti-human
CD45-FITC (BD Pharmigen, #555482), CD3-Alexa Fluor
700 (BD Biosciences #557943), CD4-APC (BD Pharmingen
#555349), CD8-BV421 (BD Horizons #562428), CD45RA-
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APC-H7 (BD Biosciences #560674), CD14-PE (BD
Pharmingen #555398), and Brilliant Stain Buffer. After
30min incubation at 4 °C, red blood cell lysis (BD Bio-
science #349202) and two washes, samples were fixed with
2% paraformaldehyde and acquisition was performed on
BD LSR II flow cytometer.
HIV-1 infection
Animals with comparable peripheral blood repopulation
with human leucocytes were infected with HIV-1ADA at
104 50% tissue culture infectious (TCID50) dose intraperi-
toneally. At four and 9 weeks post infection, animals were
euthanized for the VL analysis (COBAS® AmpliPrep/
COBAS® TaqMan® HIV-1 Test, v2.0, Roche Molecular
Systems Inc., Pleasanton, CA, USA) and human cells
phenotypes by FACS. Peripheral blood, spleen, and bone
marrow cells were analyzed as described above.
Additional bone marrow human population analysis was
performed by flow cytometry at the end of observation at
5–6 weeks post infection. Approximately 106 isolated bone
marrow cells were aliquoted into three tubes for each
mouse evaluated. The cells were washed once with 2mL
PBS and were then incubated with the 8 antibody cocktails
for 30min at room temperature in 200 uL of PBS with
10% fetal calf serum (PBS-FCS). The following antibodies
were used in combination: T-NK cocktail consisting of
APC-H7 conjugated anti-CD3 (clone SK7), PE-Cy7 conju-
gated anti-CD4 (clone SK3), PE conjugated anti-CD7
(clone 8G12), PerCP-CY5–5 conjugated anti-CD8 (clone
SK1), FITC conjugated anti-CD14 (clone MϕP9), V450
conjugated anti-CD16 (clone 3G8), APC conjugated anti-
CD56 (clone NCAM16.2), and V500c–conjugated CD45
(clone 2D1); MYELO cocktail consisting of APC-H7 con-
jugated anti-HLA-DR (clone L243), PE conjugated anti-
CD10 (clone H10a), PE-Cy7 conjugated anti-CD13 (clone
L138), APC conjugated anti-CD24 (clone 2G5), V450
conjugated anti-CD33 (clone WM53), FITC conjugated
anti-CD34 (clone 8G12), PerCP-CY5–5 conjugated anti-
CD117 (clone 95C3), and V500c–conjugated CD45 (clone
2D1); and the BCL tube consisting of FITC conjugated
anti-kappa (clone TB28–2), PE conjugated anti-lambda
(clone 1–155-2), PE-Cy7 conjugated anti-CD10, PerCP-
Cy5.5 conjugated anti-CD19 (clone SJ25C1), APC-H7
conjugated anti-CD20 (clone L27), APC conjugated anti-
CD24 (clone 2G5), V450 conjugated anti-CD38 (clone
HB7), and V500c–conjugated CD45 (clone 2D1). All anti-
bodies were obtained from BD Biosciences (Franklin
Lakes, NJ, USA) except CD24 and CD117, which were
obtained from Beckman Coulter (Brea, CA, USA).
After incubation, the cells were washed twice with 1mL
PBS and were resuspended in 500 uL PBS containing
stabilizer (BD Biosciences) to fix the cells. Fifty thousand
to 100,000 cell events were collected for each sample on a
Becton Dickinson FACS Canto II (Franklin Lakes, NJ,
USA). Analysis of the FCS files was performed using
Kaluza 1.3 analysis software (Beckman Coulter).
Gating schemes for the bone marrow analysis are
shown in the Additional file 6: Figure S6.
For all bone marrow cell populations characterized,
total cell events were derived based on gating and logical
antigen (Boolean) profiles. Population frequencies were
then derived by dividing the specific cell population events
by the total human cell events after CD45 and singlet
gating.
HIV-1 viral clearance
Viral clearance naïve non-humanized animals were injected
with HIV-1 stock 3 × 103 TCID50/mouse), and blood was
collected on days 1, 2, 5, and 7 post inoculation. Number
of viral RNA copies were determined as described above.
Recombinant adeno-associated virus biodistribution
NSG-cmah−/− and wild type NSG mice were injected
intravenously with rAAV2/DJ EF1a-luciferase 1.825E+ 11
GE/mouse (Viral Vector Core, University of Iowa, Iowa
City, IA; Cat No. Uiowa-6161: Lot AAV3240; http://www.
medicine.uiowa.edu/vectorcore/). D-Luciferin Biolumines-
cent Substrate (Cat 770,504, PerkinElmer, Waltham, MA,
USA) was used for in vivo detection. The biodistribution of
luminescence was analyzed by IVIS® Spectrum an in vivo
imaging system at 1, 2, and 4 weeks after rAAV administra-
tion to validate and compare transduction efficiency. Liver,
spleen, and brain tissues were collected at day 32 for detec-
tion of luciferase gene on droplet digital PCR (ddPCR)
(QX200™ Droplet Digital™ PCR System, Bio-Rad, Hercules,
CA, USA) with forward primer 5’CTTCGAGGAGGAGC
TATTCTT-3′, reverse primer 5’-GTCGTACTTGATGA
GAGTG-3′, and luciferase probe 5′−/56 FAM/TGCT
GGTGC/ZEN/CCACACTATTTAGCT/3IABKFQ/− 3′
(Integrated DNA Technologies, Inc., Coralville, IA, USA).
Briefly, isolation of RNA was performed using a RNeasy
Plus Universal Kit (Qiagen, Hilden, Germany) as per the
manufacturer’s instructions. The final PCR reaction was
comprised of ddPCR supermix (Bio-Rad), 20 U/μl reverse
transcriptase, 15mM Dithiothreitol (DTT), 900 nM primers,
250 nM probe, and 100 ng of RNA template in a final vol-
ume of 20 μl and loaded into an eight-channel disposable
droplet generator cartridge (Bio-Rad). Generated droplets
were then transferred into a 96-well PCR plate, heat-sealed
with foil and then amplified to endpoint using a BioRad
C1000 Touch PCR cycler at 95 °C for 10min then 40 cycles
of 94 °C for 15 s and 60 °C for 1min (2 °C/s ramp rate) with
a final step at 98 °C for 10min and 4 °C hold. Plates contain-
ing amplified droplets were loaded into a QX200 droplet
reader (Bio-Rad). Discrimination between negative droplets
(no luciferase copies) and positives (with luciferase copies)
was used to estimate concentration of targets (luciferase
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copies/ul) using QuantaSoft analysis software (Bio-Rad).
The resulted copies were normalized to input RNA and
represented as luciferase copies in log scale.
Human IgG clearance
We compared the circulation time of human IgG (IVIG,
PRIVIGEN, CSL Behring LLC). NSG-cmah−/− and control
mice were injected with 100 μl of 10% IVIG in saline.
Blood samples were collected at 30min after IVIG injec-
tion as point day 0. The actual concentration of human
IgG in peripheral blood was measured at days 1, 2, 3, 6, 7,
and 14. Plasma human IgG concentration was determined
by ELISA kit (Bethyl Laboratories, Inc. Montgomery, TX,
USA, cat# E80–104).
Additional files
Additional file 1: Figure S1. Human immune cell IGH gene CDR3
length frequency distribution in bone marrow. a Histograms of IgH
CDR3 length in bone marrow of NSG-cmah−/− and b NSG mice. c The
NSG-cmah−/− background was associated with a lower clonal B-cell outgrowth
and subsequently a lower maximal frequency of templates. d The frequency
of CDR3 lengths can be seen to show a more gaussian distribution in the
NSG-cmah−/− mice although the number of total IGH templates was
not statistically different. e Statistical analysis was performed using
immunoSEQ Analyzer (https://www.adaptivebiotech.com/). Five animals
per strain were used. (PDF 1482 kb)
Additional file 2: Figure S2. IgH CDR3 length in bone marrow and
spleen in NSG-cmah−/− (m158, 103, 96, 159, 154) and NSG wild type
mice (M376, 3578, 3571, 3577, 3573). Arrows indicate shortening of CDR3
length in spleen (orange bars) compared to the bone marrow (blue bars)
samples in the same animal. (PDF 1537 kb)
Additional file 3: Figure S3. IGH genes family usage. a Individual IgH
genes families usage in NSG-cmah−/− and b NSG wt mice represent the
summary of productive rearrangement frequency in spleen tissue
samples. Similar profiles were found in bone marrow (not shown). c The
frequency of V, D and J genes family usage in bone marrow and spleen
tissue are highly similar in both strains as expected. As shown, there are
no significant differences between NSG and NSG-cmah−/− mice in overall
IgH gene family usage. In both strains, a significant reduction in the
frequency of IGHD02 usage was apparent in splenic B-cells compared to
bone marrow. Mild increased frequencies in IGHD01, IGD06, and IGD07
usage was also noted in NSG-cmah−/− splenic tissue. In NSG wt mice,
only IGD03 usage was increased in splenic B-cells compared to bone
marrow. For J family usage, an increase in IGHJ03 frequency was found in
NSG-cmah−/− splenic B-cells with a reduction of IGHJ05 and IGHJ06
usage. Statistical analysis was done by two-way ANOVA with Fisher’s LSD
test. P < 0.05 (*) considered significant. (PDF 2063 kb)
Additional file 4: Figure S4. Spleen TCRβ chain gene usage. a
Individual TCRβ chain gene families usage in NSG-cmah−/− and b NSG wt
mice represent the frequency of productive rearrangements TCRβ in
spleen tissue samples. Similar profiles were found in bone marrow (not
shown). (PDF 520 kb)
Additional file 5: Figure S5. Human TCRβ chain genes CDR3 size
frequency distributions in spleen and repertoire characteristic in bone
marrow and spleen. a Histograms of TCRβ chain gene CDR3 length in
bone marrow of NSG-cmah−/− and b NSG mice. c NSG-cmah−/−
background was associated with lower clonal frequencies in spleen (Spl)
compared to bone marrow (BM), which was statistically significant by
one-way paired t-test (P = 0.0381) for NSG-cmah−/− mice. Five animals per
strain were used. d The richness of TCRβ chain gene repertoire in both
strains was higher in spleen compared to bone marrow (*P < 0.05), while
the number of total TCRβ chain gene templates was not statistically
different between strains (not shown). e The Pielou’ evenness of
repertoires in the bone marrow and splenic compartments was not
significantly different in both strains; however, the evenness was higher in
the spleens of NSG-cmah−/− mice (paired t-test, P = 0.0312). Red dashed line
highlights higher evenness of TCRβ in NSG-cmah−/− strain compared to
wild type NSG by Mann Whitney test (P = 0.0446). (PDF 1626 kb)
Additional file 6: Figure S6. Humanized bone marrow gating
strategies. The percentage of lymphocytes was enumerated based on
two CD45 by light scatter displays so that cells had to be present in both
gates to be considered lymphocytes. T-cells, NK-cells, and monocytes
were enumerated using a T/NK-cell cocktail containing CD3, CD4, CD7,
CD8, CD14, CD16, and CD56. T-cells were identified as CD3+, low side
light scatter events and were further characterized for CD4 and CD8 ex-
pression. NK-cells were isolated using a low side light scatter (SS) gate on
the CD45 by side light scatter histogram. The low SS cells were character-
ized for CD56 and CD16 expression to enumerate the two NK-cell subsets
(not shown here). Monocytes were isolated using a Boolean logic gate as
CD4dim and CD3neg cells. Promonocytes and mature monocytes were
identified based on CD14 expression density. CD19+, CD10+, and CD20+
B-cells were enumerated using a B-cell specific cocktail containing kappa,
lambda, CD10, CD19, CD20, CD24, and CD38. CD19-positive, low SS cells
were gated to enumerate total B-cells and precursors. The CD19-positive
B-cells were characterized for expression of CD10 to identify the B-cell
precursors and CD20 to identify transitional to mature B-cells. Myeloblasts,
proB-cells, preB-cells, mast cells, and granulocytes were enumerated using
a myeloid cell cocktail containing HLA-DR, CD10, CD13, CD24, CD33,
CD34, and CD117. CD34-positive events were gated on a CD34 by SS
histogram and were characterized as myeloblasts or pro B-cells based on
the CD45 by SS profile. Total B-cell precursors were isolated based on
HLA-DR, CD10, and CD24 co-expression. PreB-cells were calculated using
Boolean logic as total B-cell precursors and not proB-cells. Mast cells were
enumerated as CD117bright events on a CD34-positive by CD117 display.
Finally, the granulocytes were estimated based on a CD45 by high SS
gate that excluded the CD117bright mast cells. (PDF 1680 kb)
Additional file 7: Figure S7. Profile of human cells in NSG-cmah−/− at
9 weeks post HIV-1 infection. NSG-cmah−/− mice were infected with
HIV-1ADA intraperitoneally at 5 months of age. At 9 weeks post-infection,
samples were collected for FACS analyses of the peripheral blood, spleen,
and bone marrow. A, Human cell profile in peripheral blood. FACS gating
strategies used: human CD45/CD3/CD14; CD3/CD4/CD8; CD4/CD45RO.
B, For spleen additional analysis included: human CD45/CD14/CD123/CD1c
and CD45/CD19. C, Bone marrow analyses was done for CD45/CD3/CD19
and lineage negative CD3−/CD19− human CD34+ and CD33-positive
cells. Individual mouse and means with SEM are shown. P values were
determined with Mann-Whitney test. P≤ 0.05 were considered significant.
Reconstituted at variable levels, NSG-cmah−/− mice showed high sensitivity
to HIV-1 infection with significantly decreased numbers of human T-cells
(predominantly helper T-cells) and CD4+CD45RO+ memory T-cells in
peripheral blood and spleen. In contrast, CD19-positive mature B-cells
(spleen) and B-cell precursors (bone marrow) were significantly increased in
NSG-cmah−/− mice following HIV exposure. Results for NSG mice at 9 weeks
after HIV-1 infection not shown as only 3 animals were available for FACS
analyses with significant variability. (PDF 951 kb)
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